Castle Biosciences Inc is a molecular diagnostics company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CSTL is expected to report earnings to fall 17.80% to -40 cents per share on July 30
Q2'26
Est.
$-0.40
Q1'26
Est.
$-0.49
Q4'25
Beat
by $0.24
Q3'25
Beat
by $0.50
Q2'25
Beat
by $0.66
The last earnings report on May 06 showed earnings per share of -49 cents, meeting the estimate of -49 cents. With 348.27K shares outstanding, the current market capitalization sits at 741.87M.